Chemoprevention of benzo(a)pyrene-induced lung tumors in mice by the farnesyltransferase inhibitor R115777

Clinical Cancer Research

Volumn 9, Issue 5, 2003, Pages 1927-1930

  Gunning, William T ^a   Kramer, Paula M ^a   Lubet, Ronald A ^b   Steele, Vernon E ^b   End, David W ^c   Wouters, Walter ^d   Pereira, Michael A ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^d JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; RAS PROTEIN; TIPIFARNIB;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE MUTATION; LUNG CARCINOGENESIS; LUNG TUMOR; MOUSE; NONHUMAN; ONCOGENE K RAS; PRIORITY JOURNAL;

ALKYL AND ARYL TRANSFERASES; ANIMALS; ANTINEOPLASTIC AGENTS; BENZO(A)PYRENE; CHEMOPREVENTION; ENZYME INHIBITORS; FEMALE; LUNG NEOPLASMS; MICE; MICE, INBRED A; QUINOLONES;

EID: 0037989766     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Cox, A. D. Farnesyltransferase inhibitors: potential role in the treatment of cancer. Drugs, 61: 723-732, 2001.
2. Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., and Tuveson, D. A. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev., 15: 3243-3248, 2001.
3. Hahn, S. M., Bernhard, E., and McKenna, W. G. Farnesyltransferase inhibitors. Semin. Oncol., 28: 86-93, 2001.
4. Kohl, N. E. Farnesyltransferase inhibitors. Preclinical development. Ann. N. Y. Acad. Sci., 886: 91-102, 1999.
5. Lantry, L. E., Zhang, Z., Crist, K. A., Wang, Y., Hara, M., Zeeck, A., Lubet, R. A., and You, M. Chemopreventive efficacy of promising farnesyltransferase inhibitors. Exp. Lung Res., 26: 773-790, 2000.
6. Oliff, A. Farnesyltransferase inhibitors: targeting the molecular basis of cancer. Biochim. Biophys. Acta, 1423: C19-C30, 1999.
7. Gibbs, J. B., Graham, S. L., Hartman, G. D., Koblan, K. S., Kohl, N. E., Omer, C. A., and Oliff, A. Farnesyltransferase inhibitors versus Ras inhibitors. Curr. Opin. Chem. Biol., 1: 197-203, 1997.
8. End, D. W. Farnesyl protein transferase inhibitors and other therapies targeting the Ras signal transduction pathway. Invest. New Drugs, 17: 241-258, 1999.
9. End, D. W., Smets, G., Todd, A. V., Applegate, T. L., Fuery, C. J., Angibaud, P., Venet, M., Sanz, G., Poignet, H., Skrzat, S., Devine, A., Wouters, W., and Bowden, C. Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro. Cancer Res., 61: 131-137, 2001.
10. Crul, M., de Klerk, G. J., Swart, M., Weiner, L., Palmer, P. A., Bol, C. J., Beijnen, J. H., and Schellens, J. H. Evaluation of the bioequivalence of tablets and capsules containing the novel anticancer agent R115777 (Zarnestra) in patients with advanced solid tumors. Eur. J. Drug Metab. Pharmacokinet., 27: 61-65, 2002.
11. Foley, J. F., Anderson, M. W., Stoner, G. D., Gaul, B. W., Hardisty, J. F., and Maronpot, R. R. Proliferative lesions of the mouse lung: progression studies in strain A mice. Exp. Lung Res., 17: 157-168, 1991.
12. Gunning, W. T., Castonguay, A., Goldblatt, P. J., and Stoner, G. D. Strain A/J mouse lung adenoma growth patterns vary when induced by different carcinogens. Toxicol. Pathol., 19: 168-175, 1991.
13. Lantry, L. E., Zhang, Z., Yao, R., Crist, K. A., Wang, Y., Ohkanda, J., Hamilton, A. D., Sebti, S. M., Lubet, R. A., and You, M. Effect of farnesyltransferase inhibitor FTI-276 on established lung adenomas from A/J mice induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis (Lond.), 21: 113-116, 2000.
14. Pereira, M. A., Li, Y., Gunning, W. T., Kramer, P. M., Al-Yaqoub, F., Lubet, R. A., Steele, V. E., Szabo, E., and Tao, L. Prevention of mouse lung tumors by budesonide and its modulation of biomarkers. Carcinogenesis (Lond.), 23: 1185-1192, 2002.
15. You, M., Candrian, U., Maronpot, R. R., Stoner, G. D., and Anderson, M. W. Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc. Natl. Acad. Sci. USA, 86: 3070-3074, 1989.